The goal of this activity is for learners to be better able to discuss newly-approved treatment options for patients with ATTR-CM and consider how to incorporate new therapies into the treatment landscape.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001970
- Start Date: 2024-12-02 06:00:00
- End Date: 2024-12-02 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: BridgeBio - Amount: 62500.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest